Weight-Adjusted Waist Index Positively Tied to Overactive Bladder
By Lori Solomon HealthDay Reporter
TUESDAY, Oct. 1, 2024 -- The weight-adjusted waist index (WWI) may be able to predict future incidence of overactive bladder (OAB) in adults, according to a study published online Sept. 3 in Frontiers in Nutrition.
Zeng Hui, from the Third Xiangya Hospital at Central South University in Changsha, China, and colleagues used data from the National Health and Nutrition Examination Survey (2009 to 2018; 35,950 individuals) to examine the correlation between WWI and OAB.
The researchers found that individuals with a higher WWI had a higher risk for OAB (odds ratio, 1.41). The relationship between WWI and OAB was consistent across various population characteristics. There was a positive nonlinear relationship between WWI and OAB in smoothing curve fitting. The association between WWI and OAB was stronger than with other obesity-related indicators.
"In this study, we found a positive relationship between higher WWI levels and an increased risk of OAB," the authors write. "Furthermore, the relationship between WWI and OAB is stronger than the correlation between other obesity markers and OAB, indicating that WWI may serve as a simple anthropometric indicator for predicting OAB."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity
TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...
GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression
MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...
Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery
THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.